Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R. Janes, Jose J. Limon, Lomon So et al.|Nature Medicine|2010Cited by 338
A Single-cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid LeukemiaVaidehi Krishnan, S. Tiong Ong, Mengge Yu et al.|Blood|2023Cited by 36
Identification of cis-Acting Elements and Splicing Factors Involved in the Regulation of BIM Pre-mRNA SplicingWen Chun Juan, S. Tiong Ong|PLoS ONE|2014Cited by 34
The <i>BIM</i> deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemiaTun Kiat Ko, S. Tiong Ong|Oncotarget|2015Cited by 19
A Single-Cell Atlas Identifies Pretreatment Features of Primary Imatinib Resistance in Chronic Myeloid LeukemiaVaidehi Krishnan, S. Tiong Ong, Florian Schmidt et al.|Blood|2022Cited by 15